tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market
RDY
Dr Reddy's Laboratories
RESEARCH TOOLSreports
Want to see RDY full AI Analyst Report?

Dr Reddy's Laboratories (RDY) Income Statement

450 Followers

Dr Reddy's Laboratories Income Statement

Last quarter (Q3 2026), Dr Reddy's Laboratories's total revenue was ₹87.27B, an increase of 4.41% from the same quarter last year. In Q3, Dr Reddy's Laboratories's net income was ₹12.10B. See Dr Reddy's Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B₹ 2.56B
Gross Profit
₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B₹ 1.30B
Operating Expenses
₹ 118.58B₹ 95.88B₹ 82.20B₹ 84.36B₹ 866.36M
Depreciation and Amortization
₹ 17.06B₹ 14.84B₹ 12.64B₹ 11.82B₹ 172.37M
EBITDA
₹ 96.67B₹ 88.42B₹ 74.43B₹ 45.08B₹ 534.77M
Operating Income
₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B₹ 431.44M
Other Income/Expenses
₹ 4.94B₹ 4.14B₹ 3.22B₹ 2.82B₹ -75.64M
Pretax Income
₹ 76.78B₹ 71.87B₹ 60.37B₹ 32.30B₹ 355.80M
Net Income
₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B₹ 232.21M
Per Share Metrics
Basic EPS
₹ 67.85₹ 66.80₹ 54.29₹ 28.42₹ 20.79
Diluted EPS
₹ 67.77₹ 66.80₹ 54.17₹ 28.34₹ 20.73
Weighted Average Shares Outstanding
 833.31M 833.54M 830.17M 829.41M 829.22M
Weighted Average Shares Outstanding (Diluted)
 834.30M 833.54M 831.91M 831.69M 831.58M
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History